Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Histamine-, norepinephrine-, and dopamine-sensitive central adenylate cyclases: effects of chlorpromazine derivatives and butaclamol.

Palmer GC, Wagner HR, Palmer SJ, Manian AA.

Arch Int Pharmacodyn Ther. 1978 Jun;233(2):314-25.

PMID:
687395
2.

Di- and trihydroxy analogs of chlorpromazine influence the central activity of adenylate cyclase and cyclic AMP phosphodiesterase.

Palmer GC, Legendre JL, Manian AA.

Arch Int Pharmacodyn Ther. 1980 Sep;247(1):59-70.

PMID:
6255882
3.
6.

Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.

Onali P, Olianas MC, Gessa GL.

Mol Pharmacol. 1985 Aug;28(2):138-45.

PMID:
2410769
9.

Role of neuroleptic agents on mouse pulmonary cyclic nucleotide systems.

Palmer GC, Jones DJ, Medina MA, Palmer SJ, Stavinoha WB.

Pharmacology. 1978;17(5):280-7.

PMID:
30096
10.

Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.

Prémont J, Tassin JP, Thierry AM, Bockaert J.

Adv Biochem Psychopharmacol. 1976;15:347-56.

PMID:
192054
11.

N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.

Lewis MH, Widerlöv E, Knight DL, Kilts CD, Mailman RB.

J Pharmacol Exp Ther. 1983 Jun;225(3):539-45.

PMID:
6134814
12.

Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging.

Makman MH, Ahn HS, Thal LJ, Sharpless NS, Dvorkin B, Horowitz SG, Rosenfeld M.

Brain Res. 1980 Jun 16;192(1):177-83.

PMID:
7378778
14.

Stereospecific antagonism by d-butaclamol of dopamine-induced relaxation of the isolated rabbit mesenteric artery.

Brodde OE, Freistühler J, Meyer FJ.

J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):828-37.

PMID:
6167812
15.
16.

Effect of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum.

Miller RJ, Iversen LL.

J Pharm Pharmacol. 1974 Feb;26(2):142-4. No abstract available.

PMID:
4150834
17.

Modification of adenylate cyclase systems in mouse cerebral cortex by chlorpromazine and respective 7-hydroxy analogs.

Cotter GW, Palmer GC, Palmer SJ, Manian AA.

Commun Psychopharmacol. 1978;2(1):51-8. No abstract available.

PMID:
657781
18.
19.

Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.

Bockaert J, Premont J, Glowinski J, Tassin JP, Thierry AM.

Adv Biochem Psychopharmacol. 1977;16:29-37. No abstract available.

PMID:
196489
20.

Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.

Heijna MH, Bakker JM, Hogenboom F, Mulder AH, Schoffelmeer AN.

Eur J Pharmacol. 1992 Dec 15;229(2-3):197-202.

PMID:
1337044

Supplemental Content

Support Center